Journal of Transcatheter Valve Therapies
Online ISSN : 2434-4532
Case Report
Emergency Transcatheter Mitral Valve Edge-to-edge Repair for Acute Ischemic Papillary Muscle Rupture in a Patient with Cardiogenic Shock due to Acute Coronary Syndrome
Natsuki ChoYoshifumi NakajimaYoshihiro Morino
Author information
JOURNAL OPEN ACCESS
Supplementary material

2022 Volume 4 Issue 1 Pages 51-55

Details
Abstract

Objective: Acute mitral regurgitation (MR) secondary to papillary muscle rupture (PMR) is a lethal complication of acute coronary syndrome. Although surgery is considered the first-line therapy for this condition, some of these patients have no choice but to quit with prohibitively high surgical risk. Transcatheter mitral valve edge-to-edge repair (TEER) using the MitraClip system (Abbott Vascular, Santa Clara, CA, USA) is an established treatment option and viable alternative for patients with high-risk or prohibitive-risk open heart surgery.

Case Presentation: We present a case of successful TEER for a patient with severe MR due to PMR after acute myocardial infarction using the MitraClip. The patient, who had post-gastrectomy peritonitis, was in a critical condition. After a few days, he developed acute heart failure with cardiogenic shock. Emergency angiography revealed severe left main-trunk stenosis. A percutaneous coronary intervention was performed for the culprit lesion under a ventilator and an intra-aortic balloon pump support. Echocardiography revealed massive MR with a partial tear in the posteromedial papillary muscle and a large regurgitant jet directed to the posterior wall with severely reduced left ventricular function. We performed TEER using three clips, which resulted in mild residual MR. Subsequently, the patient was hemodynamically stabilized.

Conclusion: TEER with the MitraClip system is a viable treatment option for cardiogenic shock due to PMR.

Content from these authors
© 2022 Japan Transcatheter Valve Therapies

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top